Physician profile
John Brady
NPI 1205141678
$1,354.92
in general payments reported to CMS, 2019-2025
10 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $175 · 2021: $16.01 · 2022: $23.50 · 2024: $190 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311 · Education: $21.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.94 |
| Education | $21.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Henry Schein, INC. | $801.94 | 2019-2020 | |
| Gilead Sciences, INC. | $206.83 | 2024-2025 | |
| Dentsply Sirona INC | $137.98 | 2019-2021 | |
| Solventum Corporation | $72.89 | 2024-2025 | Filtek, 3m Clinpro, Clinpro 5000 |
| Envista Holdings Corporation | $40.94 | 2024 | K3, Harmonize |
| 3m Company | $31.12 | 2020 | |
| Zimvie INC. | $23.50 | 2022 | |
| Biohorizons Implant Systems INC. | $15.15 | 2020 | |
| Zimmer Biomet Holdings, INC. | $12.97 | 2019 | |
| Align Technology, INC. | $11.60 | 2025 | Invisalign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.